Michael D. Schreiber to Treatment Outcome
This is a "connection" page, showing publications Michael D. Schreiber has written about Treatment Outcome.
Connection Strength
0.223
-
Efficacy of inhaled nitric oxide in neonates with hypoxic respiratory failure and pulmonary hypertension: the Japanese experience. J Perinat Med. 2018 Aug 28; 46(6):657-663.
Score: 0.065
-
Physician counseling, informed consent and parental decision making for infants with hypoplastic left-heart syndrome. J Perinatol. 2012 Oct; 32(10):748-51.
Score: 0.042
-
Safety and efficacy of inhaled nitric oxide treatment for premature infants with respiratory distress syndrome: follow-up evaluation at early school age. Acta Paediatr. 2011 Apr; 100(4):524-8.
Score: 0.038
-
Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med. 2005 Jul 07; 353(1):23-32.
Score: 0.026
-
Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome. J Med Assoc Thai. 2002 Aug; 85 Suppl 2:S469-78.
Score: 0.021
-
Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics. 2011 Oct; 128(4):729-39.
Score: 0.010
-
Inhaled nitric oxide in preterm infants: a systematic review and individual patient data meta-analysis. BMC Pediatr. 2010 Mar 23; 10:15.
Score: 0.009
-
Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr. 2008 Aug; 153(2):183-9.
Score: 0.008
-
Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med. 1997 Feb 27; 336(9):605-10.
Score: 0.004